Amorphous selenium nanodots alleviate non-alcoholic fatty liver disease via activating VEGF receptor 1 to further inhibit phosphorylation of JNK/p38 MAPK pathways
Mo‐Li Zhu, Qianqian Niu, Jie Zhang, Yanan Yu, Huanhuan Wang, Tiantian Zhu, Ge Wang, Lin Yang, Yaling Yin, Peng Li
Topics & Concepts
Fatty liverSteatosisLiver functionOxidative stressEndocrinologyInternal medicineMAPK/ERK pathwayMedicineLiver diseaseLiver injuryp38 mitogen-activated protein kinasesCancer researchPhosphorylationChemistryDiseaseBiochemistryLiver Disease Diagnosis and TreatmentSelenium in Biological SystemsCurcumin's Biomedical Applications